Clinical Trial Update: Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid [NA]

View source ↗

Summary

A clinical trial evaluating genetic predictors of bisphosphonate-related osteonecrosis of the jaw in cancer patients treated with zoledronic acid has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Osteonecrosis of the Jaw

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: University of Southern California | Conditions: Malignant Neoplasm, Musculoskeletal Complications | NA | Status: WITHDRAWN